Safety of bowel cleansers (Q17-03)

Safety of bowel cleansers (Q17-03)

Q17-03

Overview

Background
  • Colonoscopy is among the most commonly performed surgical procedures in North America.
  • Although the stimulant laxative, bisacodyl, is frequently prescribed alongside colonoscopy bowel cleansers, little is known about the utilization and safety of bisacodyl in real-world practice.
Aims of the study
  • To determine the annual number of patients dispensed commonly-prescribed colonoscopy bowel cleansers (alone vs combined with bisacodyl), and to estimate the relative risk of selected adverse clinical outcomes associated with receipt of bisacodyl.

Manuscripts

Presentations

Project Team

Project Lead
Michael Paterson MSc
Content Expert
Matthew Weir
Research Assistant
Audray St-Jean MSc
Site Investigator
Jordan Hunt
British Columbia
Site Investigator
Dan Chateau PhD
Manitoba
Site Investigator
Michael Paterson MSc
Ontario
Site Investigator
Colin R. Dormuth ScD
MarketScan
Analyst
Kathy Lee
British Columbia
Analyst
Matthew Dahl BSc
Manitoba
Analyst
Paramdeep Kaur
MarketScan
Analyst
Fangyun Wu MSc
Ontario